Gut Microbiota Research & Practice is a section dedicated to promoting knowledge-sharing and debate among researchers, scientists and healthcare professionals. You will find a selection of discussions about articles from scientific literature as well as other content including interviews with experts, event reports, and special publications.
by Andreu Prados
The gut-brain connection is largely shaped by the composition and function of gut-dwelling microbial communities. This review article addresses how the brain and gut communicate and considers potential psychobiotic therapies.
by Joël Doré, Andreu Prados
The 10th Gut Microbiota for Health World Summit took place on March 12th and 13th 2022, focusing on the role of gut microbiome-related interventions as part of individualized nutrition and medicine. This post highlights the major learnings from the conference and how they might impact clinical practice in the foreseeable future.
by Andreu Prados
The involvement of the gut microbiota in diverticulitis is gaining interest. This article explores what we know so far about the role of the gut microbiota in diverticulitis and discusses two recent clinical trials on the role of probiotics in managing acute uncomplicated diverticulitis.
by Rene van den Wijngaard
Alterations in the gut microbiome in early life have been associated with increased risk of inflammatory bowel diseases. New findings in mice have found a keystone Bacteroides strain that reduces colitis risk when engrafted during early life in a gut microbiome disrupted by antibiotics.
In a series of 7 webinar this programme will develop a full picture of the C. difficile infection (CDI) reaching from the importance of a healthy gut microbiota, to its detection and testing methods to current and future therapeutic approaches.
by Konstantina Zafeiropoulou
The first 2-3 years of life are crucial for shaping childhood health. Amid others, the importance of early-life gut microbiota in infant’s development and later human health has been long speculated. In particular, bifidobacteria are playing an essential role in infant’s gut microbiota and immune system maturation that supports its probiotic use in that age span.
by GMFH Editing Team
Whether you’re thinking of attending in person or via livestream, it’s the last call for registrations! So even if you can’t join us in Washington D.C, you can still be part of the #GMFH2022 Summit. You just need to register to follow the plenary sessions online.
by Andreu Prados
Clostridioides difficile infection is the most frequent cause of antibiotic-associated diarrhea in the hospital setting that has increased in severity. This article looks at the risk factors for developing C. difficile-associated disease, the spectrum of manifestations and the impact of the COVID-19 pandemic on the occurrence of C. difficile infection.
In Western world, the incidence of autoimmune and autoinflammatory diseases has been significantly increasing and also the use of non-antibiotic drugs for their treatment. Scientists at EMBL and Cambridge University elucidate how common drugs accumulate in gut bacteria and potentially reduce medication’s effectiveness.
by GMFH Editing Team, Rene van den Wijngaard
Despite the global focus on COVID-19, 2021 was also a productive year in gut microbiome research. In this “2021 Year at a glance” report, discover emerging trends in postbiotics, the role of beneficial microbes in dietary guidelines, diet-related tools for shaping the gut microbiome and the potential role of newly identified probiotics in obesity and functional dyspepsia.
